← Back to Search

Behavioural Intervention

Heat Therapy for High Blood Pressure

N/A
Recruiting
Led By Douglas R Seals, PhD
Research Sponsored by University of Colorado, Boulder
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Premenopausal women must not be pregnant (confirmed by urine pregnancy test)
Aged 50+ years
Must not have
Any rectal, anal, vaginal, or prostate surgery within the last 3 months, current or recent (within the last 3 months) hemorrhoids, or related concerns regarding use of rectal thermistor
Unstable cardiovascular diseases (e.g., unstable angina or recent myocardial infarction or stroke) (rationale: heat therapy is contraindicated for individuals with unstable CVDs)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 7 months

Summary

This trial is testing if taking regular hot baths can improve blood pressure and blood vessel function in adults aged 50 and older. The idea is that hot water might help relax blood vessels and improve blood flow, which could lower blood pressure.

Who is the study for?
This trial is for adults aged 50 or older with systolic blood pressure between 120-159 mmHg. Participants must be mentally capable of consent, not pregnant, weight stable, and willing to maintain their lifestyle throughout the study. They should be healthy enough for heat exposure but can't join if they have unstable heart conditions, take multiple anti-hypertensive drugs (except one or two), do intense regular exercise, have recent major health changes including surgery or COVID-19.
What is being tested?
The study tests whether hot water immersion ('heat therapy') versus thermoneutral water immersion over approximately 12 weeks can lower blood pressure and improve vascular function in middle-aged and older adults.
What are the potential side effects?
Potential side effects may include discomfort from prolonged water immersion, skin sensitivity to pool chemicals, dehydration due to heat exposure, dizziness or fainting during temperature changes.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am not pregnant, confirmed by a test.
Select...
I am 50 years old or older.
Select...
My weight has been stable, changing by no more than 2 kg in the last 3 months.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have not had rectal, anal, vaginal, or prostate surgery in the last 3 months.
Select...
I do not have unstable heart conditions like recent heart attacks.
Select...
I do not have a significant drop in blood pressure when standing up.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 7 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 7 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in casual systolic blood pressure from baseline to 2, 4, 6, 8, 10, and 12 weeks of heat therapy, and 4 and 12 weeks of follow-up.
Secondary study objectives
Change in 24-hour ambulatory systolic blood pressure from from baseline to 2, 4, 6, 8, 10, and 12 weeks of heat therapy, and 4 and 12 weeks of follow-up.
Change in brachial artery flow-mediated dilation from baseline to 2, 4, 6, 8, 10, and 12 weeks of heat therapy, and 4 and 12 weeks of follow-up.
Other study objectives
Change in carotid artery beta-stiffness index from baseline to 2, 4, 6, 8, 10, and 12 weeks of heat therapy, and 4 and 12 weeks of follow-up.
Change in carotid-femoral pulse wave velocity from baseline to 2, 4, 6, 8, 10, and 12 weeks of heat therapy, and 4 and 12 weeks of follow-up.
Induced Hyperthermia
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Heat therapyExperimental Treatment1 Intervention
Hot water immersion \~3x per week for 12 weeks
Group II: Thermoneutral water immersionPlacebo Group1 Intervention
Thermoneutral water immersion \~3x per week for 12 weeks

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for aging, such as heat therapy, work primarily through mechanisms like heat-induced vasodilation and improved vascular function. These treatments enhance blood flow, reduce arterial stiffness, and lower blood pressure, which are crucial for maintaining cardiovascular health. For aging patients, these benefits are significant as they help mitigate the risk of cardiovascular diseases, improve overall vascular health, and potentially enhance quality of life by reducing symptoms associated with poor circulation and high blood pressure.
Acute Vascular Benefits of Finnish Sauna Bathing in Patients With Stable Coronary Artery Disease.Acute effect of Finnish sauna bathing on brachial artery flow-mediated dilation and reactive hyperemia in healthy middle-aged and older adults.Effects of heat and cold on health, with special reference to Finnish sauna bathing.

Find a Location

Who is running the clinical trial?

University of Colorado, BoulderLead Sponsor
124 Previous Clinical Trials
29,372 Total Patients Enrolled
10 Trials studying Aging
914 Patients Enrolled for Aging
Douglas R Seals, PhDPrincipal InvestigatorUniversity of Colorado, Boulder
7 Previous Clinical Trials
513 Total Patients Enrolled
5 Trials studying Aging
354 Patients Enrolled for Aging
Vienna E Brunt, PhDPrincipal InvestigatorUniversity of Colorado, Boulder

Media Library

Heat therapy (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05300971 — N/A
Aging Research Study Groups: Heat therapy, Thermoneutral water immersion
Aging Clinical Trial 2023: Heat therapy Highlights & Side Effects. Trial Name: NCT05300971 — N/A
Heat therapy (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05300971 — N/A
~61 spots leftby Jul 2026